NASDAQ : SUPN
Supernus Pharmaceuticals, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 41.84 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.43B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Supernus Pharmaceuticals, Inc. (SUPN) reported revenue of 865.11M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 865.11M | 718.95M | 661.82M | 607.52M | 667.24M | 579.77M |
| Cost of Revenue | 229.57M | 180.80M | 186.70M | 175.37M | 87.22M | 75.06M |
| Gross Profit | 635.54M | 538.15M | 475.12M | 432.15M | 580.02M | 504.71M |
| Selling, General & Admin | 521.30M | 422.94M | 335.78M | 336.36M | 377.22M | 304.76M |
| Research & Development | 74.55M | 90.47M | ||||
| Amortization of Goodwill & Intangibles | 98.72M | 89.46M | 77.98M | 82.39M | 82.63M | 29.99M |
| Operating Expenses | 620.03M | 512.39M | 413.76M | 418.75M | 534.40M | 425.21M |
| Operating Income | 15.51M | 25.76M | 61.36M | 13.40M | 45.61M | 79.50M |
| Interest Expense | -3.03M | -2.42M | -7.07M | -23.42M | ||
| Interest & Investment Income | 9.72M | 13.69M | 16.20M | 10.45M | 21.68M | 10.22M |
| EBT Excluding Unusual Items | 22.20M | 39.45M | 77.55M | 21.44M | 60.22M | 66.30M |
| Merger & Restructuring Charges | -2.05M | -72.92M | ||||
| Gain (Loss) on Sale of Investments | -439.00K | -439.00K | 9.00K | 14.00K | 347.00K | |
| Asset Writedown | -56.46M | -20.19M | ||||
| Other Unusual Items | -20.15M | -25.42M | 6.11M | 1.52M | 510.00K | 6.53M |
| Pretax Income | -42.80M | -49.03M | 97.87M | 2.77M | 60.74M | 73.17M |
| Income Tax Expense | 1.05M | -10.48M | 24.00M | 1.45M | 32.00K | 19.75M |
| Net Income | -43.86M | -38.55M | 73.86M | 1.32M | 60.71M | 53.42M |
| Net Income to Common | -43.86M | -38.55M | 73.86M | 1.32M | 60.71M | 53.42M |
| Shares Outstanding (Basic) | 57.83M | 56.45M | 55.10M | 54.54M | 53.67M | 53.10M |
| Shares Outstanding (Diluted) | 57.83M | 56.45M | 55.96M | 55.51M | 61.68M | 54.36M |
| EPS (Basic) | -0.76 | -0.68 | 1.34 | 0.02 | 1.13 | 1.01 |
| EPS (Diluted) | -0.76 | -0.68 | 1.32 | 0.02 | 1.04 | 0.98 |
| Free Cash Flow | 86.96M | 45.99M | 171.23M | 110.53M | 116.41M | 125.08M |
| Free Cash Flow Per Share | 1.50 | 0.81 | 3.06 | 1.99 | 1.89 | 2.30 |
| Gross Margin | 73.46% | 74.85% | 71.79% | 71.13% | 86.93% | 87.05% |
| Operating Margin | 1.79% | 3.58% | 9.27% | 2.21% | 6.84% | 13.71% |
| Profit Margin | -5.07% | -5.36% | 11.16% | 0.22% | 9.10% | 9.21% |
| Free Cash Flow Margin | 10.05% | 6.40% | 25.87% | 18.19% | 17.45% | 21.57% |
| EBITDA | 116.03M | 117.32M | 141.77M | 98.26M | 131.16M | 112.09M |
| EBITDA Margin | 13.41% | 16.32% | 21.42% | 16.17% | 19.66% | 19.33% |
| D&A For EBITDA | 100.52M | 91.56M | 80.41M | 84.86M | 85.54M | 32.59M |
| EBIT | 15.51M | 25.76M | 61.36M | 13.40M | 45.61M | 79.50M |
| EBIT Margin | 1.79% | 3.58% | 9.27% | 2.21% | 6.84% | 13.71% |
| Effective Tax Rate | 24.53% | 52.47% | 0.05% | 26.99% | ||
| Revenue as Reported | 865.11M | 718.95M | 661.82M | 607.52M | 667.24M | 579.77M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 175.88M | 128.45M | 69.33M | 75.05M | 93.12M | 203.43M |
| Short-Term Investments | 183.57M | 180.22M | 384.28M | 179.82M | 368.21M | 136.25M |
| Cash & Short-Term Investments | 359.46M | 308.67M | 453.61M | 254.87M | 461.33M | 339.68M |
| Receivables | 239.61M | 187.80M | 142.08M | 144.16M | 165.50M | 148.93M |
| Inventory | 87.11M | 82.39M | 54.29M | 77.41M | 91.54M | 85.96M |
| Prepaid Expenses | 25.03M | 65.33M | 36.09M | 16.68M | 15.78M | 27.02M |
| Total Current Assets | 711.22M | 644.18M | 686.07M | 493.11M | 734.15M | 601.59M |
| Property, Plant & Equipment | 33.08M | 37.24M | 36.02M | 42.52M | 44.08M | 52.32M |
| Long-Term Investments | 16.62M | 93.90M | 119.17M | |||
| Goodwill | 119.43M | 124.88M | 117.02M | 117.02M | 117.02M | 117.52M |
| Other Intangible Assets | 446.24M | 569.46M | 521.91M | 599.89M | 702.46M | 784.69M |
| Long-Term Deferred Tax Assets | 54.32M | 38.35M | ||||
| Other Long-Term Assets | 33.41M | 38.53M | 7.05M | 8.51M | 10.90M | 13.87M |
| Total Assets | 1.40B | 1.45B | 1.37B | 1.28B | 1.70B | 1.69B |
| Accounts Payable | 8.52M | 2.68M | 4.59M | 1.96M | 10.54M | 9.33M |
| Accrued Expenses | 224.54M | 217.81M | 180.21M | 166.26M | 185.66M | 199.47M |
| Current Portion of Long-Term Debt | 407.97M | 7.24M | ||||
| Current Portion of Leases | 7.62M | 10.61M | 6.89M | 8.33M | 6.79M | 6.48M |
| Other Current Liabilities | 44.72M | 107.07M | 100.72M | 113.64M | 76.99M | 92.86M |
| Total Current Liabilities | 285.40M | 338.17M | 292.40M | 290.20M | 687.96M | 315.38M |
| Long-Term Debt | 385.23M | |||||
| Long-Term Leases | 28.58M | 30.36M | 27.38M | 33.20M | 36.00M | 41.30M |
| Long-Term Deferred Tax Liabilities | 4.96M | 24.96M | 49.81M | 85.36M | ||
| Other Long-Term Liabilities | 21.24M | 22.40M | 7.60M | 7.80M | 42.54M | 46.04M |
| Total Liabilities | 335.21M | 390.93M | 332.34M | 356.16M | 816.30M | 873.30M |
| Common Stock | 58.00K | 57.00K | 56.00K | 55.00K | 54.00K | 53.00K |
| Additional Paid-In Capital | 584.58M | 543.83M | 479.44M | 439.49M | 408.12M | 434.34M |
| Retained Earnings | 478.12M | 517.88M | 556.43M | 482.56M | 481.25M | 379.92M |
| Comprehensive Income & Other | -280.00K | -44.00K | -189.00K | -593.00K | -3.21M | 1.54M |
| Shareholders' Equity | 1.06B | 1.06B | 1.04B | 921.52M | 886.20M | 815.85M |
| Total Liabilities & Equity | 1.40B | 1.45B | 1.37B | 1.28B | 1.70B | 1.69B |
| Total Debt | 36.20M | 40.98M | 34.27M | 41.53M | 450.76M | 440.25M |
| Net Cash (Debt) | 323.26M | 267.69M | 419.34M | 229.96M | 104.47M | 18.60M |
| Net Cash Per Share | 5.59 | 4.74 | 7.49 | 4.14 | 1.69 | 0.34 |
| Filing Date Shares Outstanding | 58.24M | 57.58M | 55.81M | 54.73M | 54.38M | 53.39M |
| Total Common Shares Outstanding | 58.25M | 57.46M | 55.74M | 54.72M | 54.25M | 53.26M |
| Working Capital | 425.82M | 306.01M | 393.67M | 202.92M | 46.19M | 286.21M |
| Book Value Per Share | 18.24 | 18.48 | 18.58 | 16.84 | 16.33 | 15.32 |
| Tangible Book Value | 496.81M | 367.38M | 396.80M | 204.61M | 66.72M | -86.36M |
| Tangible Book Value Per Share | 8.53 | 6.39 | 7.12 | 3.74 | 1.23 | -1.62 |
| Machinery | 15.59M | 14.87M | 14.48M | 14.03M | 13.11M | 14.23M |
| Construction In Progress | 206.00K | 33.00K | ||||
| Leasehold Improvements | 13.05M | 13.05M | 14.02M | 14.02M | 14.02M | 14.37M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -43.86M | -38.55M | 73.86M | 1.32M | 60.71M | 53.42M |
| Depreciation & Amortization | 100.52M | 91.56M | 80.41M | 84.86M | 85.54M | 32.59M |
| Other Amortization | 532.00K | 2.11M | 17.50M | |||
| Asset Writedown & Restructuring Costs | 56.46M | 20.19M | 15.00M | |||
| Loss (Gain) From Sale of Investments | 896.00K | -1.09M | 1.81M | -122.00K | 3.22M | 71.00K |
| Loss (Gain) on Equity Investments | -12.89M | |||||
| Stock-Based Compensation | 35.70M | 33.05M | 27.75M | 26.76M | 17.57M | 17.91M |
| Other Operating Activities | 15.46M | 37.52M | -9.85M | -13.31M | -15.20M | -12.94M |
| Change in Accounts Receivable | -43.33M | -22.30M | 2.08M | 18.77M | -16.37M | 3.87M |
| Change in Inventory | -15.12M | -7.50M | 15.81M | 6.11M | -17.86M | -14.58M |
| Change in Accounts Payable | -8.02M | -24.57M | -15.02M | -36.29M | -19.16M | 18.18M |
| Change in Other Net Operating Assets | -10.53M | -20.79M | -4.92M | 2.27M | 29.14M | -3.90M |
| Operating Cash Flow | 88.18M | 47.33M | 171.95M | 111.08M | 116.83M | 127.13M |
| Capital Expenditures | -1.23M | -1.34M | -725.00K | -551.00K | -412.00K | -2.04M |
| Cash Acquisitions | -293.09M | -311.69M | ||||
| Investment in Securities | -54.49M | 298.54M | -189.14M | 269.28M | -216.25M | 231.82M |
| Investing Cash Flow | -55.71M | 4.11M | -189.87M | 268.73M | -216.66M | -81.91M |
| Short-Term Debt Issued | 93.00M | |||||
| Long-Term Debt Issued | 800.00K | |||||
| Total Debt Issued | 93.00M | 800.00K | ||||
| Short-Term Debt Repaid | -93.00M | |||||
| Long-Term Debt Repaid | -402.50M | -138.31M | ||||
| Total Debt Repaid | -495.50M | -138.31M | ||||
| Net Debt Issued (Repaid) | -402.50M | -137.51M | ||||
| Issuance of Common Stock | 28.68M | 37.62M | 14.91M | 6.61M | 12.42M | 7.09M |
| Repurchase of Common Stock | -5.46M | -4.23M | -2.71M | -1.99M | ||
| Other Financing Activities | -31.18M | -24.26M | -22.90M | |||
| Financing Cash Flow | -7.95M | 9.13M | 12.19M | -397.88M | -10.48M | -130.42M |
| Net Cash Flow | 24.51M | 60.57M | -5.72M | -18.07M | -110.31M | -85.21M |
| Free Cash Flow | 86.96M | 45.99M | 171.23M | 110.53M | 116.41M | 125.08M |
| Free Cash Flow Margin | 10.05% | 6.40% | 25.87% | 18.19% | 17.45% | 21.57% |
| Free Cash Flow Per Share | 1.50 | 0.81 | 3.06 | 1.99 | 1.89 | 2.30 |
| Levered Free Cash Flow | 61.71M | 101.29M | 155.22M | 161.71M | 89.53M | 116.37M |
| Unlevered Free Cash Flow | 63.61M | 101.29M | 155.22M | 162.69M | 91.84M | 113.51M |
| Cash Interest Paid | 1.95M | 2.52M | 2.52M | |||
| Cash Income Tax Paid | 1.91M | 16.05M | 53.25M | 36.60M | 16.20M | 25.19M |
| Change in Working Capital | -77.00M | -75.16M | -2.05M | -9.14M | -24.24M | 3.57M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.44B | 2.85B | 2.00B | 1.58B | 1.93B | 1.55B |
| Enterprise Value | 2.12B | 2.61B | 1.63B | 1.40B | 1.85B | 1.13B |
| Last Close Price | 41.92 | 49.70 | 36.16 | 28.94 | 35.67 | 29.16 |
| PE Ratio | 27.03 | 1,201.42 | 31.76 | 29.03 | ||
| Forward PE | 10.98 | 19.33 | 19.65 | 15.34 | 30.84 | 15.73 |
| PS Ratio | 2.82 | 3.96 | 3.02 | 2.60 | 2.89 | 2.67 |
| PB Ratio | 2.30 | 2.68 | 1.93 | 1.72 | 2.18 | 1.90 |
| P/TBV Ratio | 4.91 | 7.76 | 5.03 | 7.73 | 28.90 | |
| P/FCF Ratio | 28.07 | 61.96 | 11.66 | 14.30 | 16.56 | 12.40 |
| P/OCF Ratio | 27.68 | 60.21 | 11.61 | 14.23 | 16.50 | 12.20 |
| PEG Ratio | 0.59 | 0.51 | 1.11 | 1.11 | 1.11 | 1.11 |
| EV/Sales Ratio | 2.45 | 3.63 | 2.46 | 2.30 | 2.77 | 1.95 |
| EV/EBITDA Ratio | 18.25 | 22.25 | 11.51 | 14.23 | 14.10 | 10.06 |
| EV/EBIT Ratio | 136.57 | 101.35 | 26.59 | 104.31 | 40.53 | 14.18 |
| EV/FCF Ratio | 24.36 | 56.77 | 9.53 | 12.65 | 15.88 | 9.01 |
| Debt / Equity Ratio | 0.03 | 0.04 | 0.03 | 0.04 | 0.51 | 0.54 |
| Debt / EBITDA Ratio | 0.27 | 0.31 | 0.22 | 0.37 | 3.13 | 3.55 |
| Debt / FCF Ratio | 0.42 | 0.89 | 0.20 | 0.38 | 3.87 | 3.52 |
| Net Debt / Equity Ratio | -0.30 | -0.25 | -0.41 | -0.25 | -0.12 | -0.02 |
| Net Debt / EBITDA Ratio | -2.79 | -2.28 | -2.96 | -2.34 | -0.80 | -0.17 |
| Net Debt / FCF Ratio | -3.72 | -5.82 | -2.45 | -2.08 | -0.90 | -0.15 |
| Asset Turnover | 0.61 | 0.51 | 0.50 | 0.41 | 0.39 | 0.36 |
| Inventory Turnover | 2.76 | 2.65 | 2.83 | 2.08 | 0.98 | 1.12 |
| Quick Ratio | 2.10 | 1.47 | 2.04 | 1.38 | 0.91 | 1.55 |
| Current Ratio | 2.49 | 1.91 | 2.35 | 1.70 | 1.07 | 1.91 |
| Return on Equity (ROE) | -4.15% | -3.68% | 7.55% | 0.15% | 7.13% | 6.85% |
| Return on Assets (ROA) | 0.69% | 1.14% | 2.90% | 0.56% | 1.68% | 3.11% |
| Return on Invested Capital (ROIC) | 2.16% | 3.65% | 6.99% | 0.80% | 5.09% | 6.93% |
| Return on Capital Employed (ROCE) | 1.40% | 2.30% | 5.70% | 1.40% | 4.50% | 5.80% |
| Earnings Yield | -1.82% | -1.35% | 3.70% | 0.08% | 3.15% | 3.45% |
| FCF Yield | 3.56% | 1.61% | 8.58% | 6.99% | 6.04% | 8.07% |
| Buyback Yield / Dilution | -3.33% | -0.88% | -0.81% | 10.01% | -13.47% | -1.24% |